Page 5 - Torrent Pharma

Torrent Pharma turns towards Brazil, Germany as share of US biz halves

Share of US biz in revenues down from 40% in FY16 to 21% in FY17; Brazil, Germany grow 38% & 25%

Torrent Pharma acquires two women healthcare brands from Novartis

Ahmedabad based Rs 6,600 croreTorrent Pharma has completed the acquisition of women healthcare brands Regestrone and Pregachieve for India from Swiss pharma major Novartis AG. While the company did not disclose the deal size, it is estimated to be close to Rs 500 crore. Torrent was in talks to acquire these brands since the last few months and had entered into a pact with Novartis last month to acquire the two brands. Both the brands are prescribed by gynaecologists for management of abnormal uterine bleeding, peri and post menopausal symptoms and infertility. Torrent said in a release here that women healthcare is an important therapy area for the company and it intends to focus on it in the future. "With acquisition of key brands of Elder like Shelcal and Deviry, impetus on this therapy area has also increased. Regestrone and Pregachieve will further fortify the Hormone Segment. The use of Hormones amongst the Gynaecologists is on an increase because of lifestyle changes," the ...

Torrent in talks to acquire select Novartis businesses

Deal estimated to be less than Rs 500 crore

Torrent Pharma turns around Brazilian ops; targets 5-10 products per year

The company's Brazil business recorded a growth of 35% on an annual basis to Rs 159 cr

Torrent Pharma Q2 net down 59%

Revenues from the US market fell from Rs 712 crore in Q2 FY16 to Rs 322 crore in Q2 FY17

Torrent Pharma invests Rs 188 cr to buy 75% stake in PurO Wellness

PurO Wellness is a healthcare startup with its main focus on producing organic food ingredients

Torrent Pharma acquires API unit of Glochem Industries

Acquisition will help pharma firm to vertically integrate its ANDA filings in future

Torrent Pharma: Strong base, robust outlook

Higher R&D spending and improving US pipeline to help keep growth rates healthy

Torrent Pharma Q4 PAT up 175% to Rs 375 cr

Revenues up 30% y-o-y to Rs 1,499 cr; full-year profit doubles to Rs 2,930 cr

Torrent Pharma seeks shareholder nod to raise Rs 10,500 cr

The company plans to use the funds for organic and inorganic growth

Torrent Pharma plans to raise funds via QIP, others

Company in a filing to the BSE said that its board on March 23 will consider 'the proposal for raising of funds'

Torrent Pharma's Dahej plant gets EIR from USFDA

It is the third plant of Torrent to receive USFDA approval out of its five manufacturing units